1. Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials

   • Fausto Petrelli
   • Karen Borgonovo
   • Sandro Barni

   Review 05 October 2011 Pages: 179 - 187

   

2. Histopathology of surgically treated renal tumours in young adults: a developing country perspective

   • Muhammed Mubarak
   • Javed I. Kazi
   • Syed Adeeb ul Hassan Rizvi

   Original Paper 16 November 2011 Pages: 189 - 194

3. Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo

   • Yong Liu
   • Changyun Yu
   • Yongquan Tian

   Original Paper 16 November 2011 Pages: 195 - 202

   

4. Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity

   • Nicolai Härtel
   • Thomas Klag
   • Paul La Rosée

   Original Paper 17 November 2011 Pages: 203 - 212

   

5. PAX3/7–FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization

   • Sarah N. Dumont
   • Alexander J. Lazar
   • Jonathan C. Trent

   Original Paper 17 November 2011 Pages: 213 - 220

   

6. Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer

   • Maurizio Belfiglio
   • Caterina Fanizza
   • Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO)

   Original Paper Open access 18 November 2011 Pages: 221 - 229

   

7. A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer

   • Jian Cheng
   • Minwen Ha
   • Chunyan Tong

   Original Paper 20 November 2011 Pages: 231 - 238

   

8. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer

   • LingLing Pan
   • JingYi Cheng
   • YingJian Zhang

   Original Paper 20 November 2011 Pages: 239 - 246

   

9. ARK5 is associated with the invasive and metastatic potential of human breast cancer cells

   • Xin-Zhong Chang
   • Jie Yu
   • Xu-Chen Cao

   Original Paper 22 November 2011 Pages: 247 - 254

   

10. Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery

    • Changhua Yu
    • Ren Yu
    • Tao Li

    Original Paper 22 November 2011 Pages: 255 - 259

    

11. Nodal status—its impact on prognosis in advanced ovarian cancer

    • C. Bachmann
    • S. Bachmann
    • E. F. Solomayer

    Original Paper 22 November 2011 Pages: 261 - 267

12. Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention

    • Xue-Song Li
    • Lin Yao
    • Zhi-Song He

    Original Paper 22 November 2011 Pages: 269 - 274

    

13. High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients

    • Yanan Kong
    • Shuqin Dai
    • Xiaoming Xie

    Original Paper 25 November 2011 Pages: 275 - 284

    

14. Second-line epidermal growth factor receptor inhibitors followed by third-line pemetrexed or the reverse sequence: a retrospective analysis of 83 Chinese patients with advanced lung adenocarcinoma

    • Tingting Hong
    • Ruxia Zhang
    • Dong Hua

    Original Paper 25 November 2011 Pages: 285 - 291

    

15. Hox B4 as potential marker of non-differentiated cells in human cervical cancer cells

    • Ana P. Barba-de la Rosa
    • Erika Briones-Cerecero
    • Mauricio Salcedo

    Original Paper 27 November 2011 Pages: 293 - 300

    

16. Palliative considerations in the surgical treatment of spinal metastases

    • Jan Walter
    • Rupert Reichart
    • Christian Ewald

    Original Paper 30 November 2011 Pages: 301 - 310

    

17. The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients

    • Yuliang Li
    • Jianli Geng
    • Zheng Li

    Original Paper 30 November 2011 Pages: 311 - 316

    

18. Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt’s lymphoma cells

    • Ana Carolina dos Santos Ferreira
    • Renan Amphilophio Fernandes
    • Claudete Esteves Klumb

    Original Paper 01 December 2011 Pages: 317 - 325

    

19. Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment

    • B. Elsberger
    • D. M. Paravasthu
    • J. Edwards

    Original Paper 02 December 2011 Pages: 327 - 332

    

20. Evaluation of oral chemotherapy with capecitabine and cyclophosphamide plus thalidomide and prednisone in prostate cancer patients

    • Li-Juan Meng
    • Jun Wang
    • Min Yang

    Original Paper 02 December 2011 Pages: 333 - 339

    

21. Oral tongue cancer patients show a better overall survival than base of tongue cancer patients

    • Liuyang Zhang
    • Xuan Zhou
    • Lun Zhang

    Original Paper 03 December 2011 Pages: 341 - 346

    

22. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model

    • Song Fei
    • Xing Qi
    • Qin Wei

    Original Paper 04 December 2011 Pages: 347 - 357

    

23. Mutational activation of FGFR3: no involvement in the development of renal cell carcinoma

    • C. G. Stoehr
    • R. Stoehr
    • B. Walter

    Rapid Communication 28 December 2011 Pages: 359 - 361